GLP1R and metabolic dysfunction-associated steatotic liver disease: GLP-1 exerts a particularly beneficial effect on the reduction in visceral fat, which is significant in the treatment of various metabolic disorders, including obesity, type 2 diabetes and non-alcoholic fatty liver disease.